Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

U071 - Plan B for the Dermatologic Surgeon: Management of Misbehaving Tumors

Sunday, February 18; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify clinical scenarios where additional management following mohs surgery is needed.
  • Describe treatment options for recurring tumors or deeply infiltrating tumors.
  • Review multidisciplinary approach in managing challenging tumors.

Description

At the conclusion of this session, dermatologic surgeons should be able to: 1) Identify clinical scenarios where additional management following Mohs micrographic surgery is needed; 2) Describe treatment options for recurring tumors or deeply infiltrating tumors; and 3) Review multidisciplinary approach in managing challenging tumors.

Disclosures

  • Krunic, Aleksandar L. J., MD, PhD: no financial relationships exist with commercial interests.
  • Somani, Ally-Khan, MD, PhD: Aviragen Therapeutics Inc. – C(Fees); Castle Biosciences, Inc – I(Grants/Research Funding); Cook Biotech Inc. – A(Fees);
  • Zeitouni, Nathalie C., MD: Genentech, Inc. – SP(NC);
Schedule
Sunday, February 18
4:30 PM
All faculty / Plan B for the Dermatologic Surgeon: Management of Misbehaving Tumors
Event Details
  • Date
    Sunday, February 18
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 6D
  • CME Credits
    1.00
  • Type
    New
Directors/Co-Directors
  • Ally-Khan Somani, MD, PhD, FAAD
Speakers
  • Aleksandar L. J. Krunic, MD, PhD, FAAD - Handout
  • Nathalie C. Zeitouni, MD, FAAD